在日本,与口服避孕药相关的血栓形成风险
Saki Takeshita1, Yuichi Nishioka1,2, Emiri Morita1
1Department of Public Health, Health Management and Policy, Nara Medical University, Nara, Japan.
Studies in health technology and informatics
|August 8, 2025
概括
口服避孕药 (OCPs) 含有50μg的乙inyl estradiol (EE) 显著增加了血栓形成的风险4.3倍. 较低的EE剂量显示没有增加风险,突出显示了OCP中EE含量对血栓形成风险的重要性.
科学领域:
- 药物监督 药物监督 药物监督
- 现实世界的证据生成.
- 生殖健康 生殖健康
背景情况:
- 口服避孕药 (OCP) 被广泛用于节育.
- 血栓形成是与OCP使用相关的严重潜在副作用.
- 了解与OCP配方相关的特定风险对于公共卫生至关重要.
研究的目的:
- 模拟一项针对性试验,调查OCP使用与血栓形成之间的关联.
- 评估与OCP中不同剂量的乙乙醇 (EE) 相关的血栓形成风险.
- 评估行政索赔数据对于生成有关OCP安全性的证据的有用性.
主要方法:
- 使用行政索赔数据库模拟目标试验的回顾性队列研究.
- 在OCP用户和非用户之间进行1:1的准确匹配.
- 对14554名女性进行了分析,并对血栓事件进行了随访.
主要成果:
- 与非使用者 (95% CI:2.0-6.7) 相比,使用OCPs的女性与50μg的乙乙醇 (EE) 呈现出血栓形成风险的4.3倍.
- 具有EE<50μg的OCP与1.0倍的风险相关 (95%CI:0.3-1.7),这表明没有显著的增加.
- 根据孕激素类型观察到最小的风险差异.
结论:
- OCP的配方,特别是乙乙二醇的剂量,是血栓形成风险的一个重要因素.
- 来自行政索赔数据库的现实数据分析可以为公共卫生研究和药物安全提供有价值的证据.
- 这项研究强调需要在临床实践中仔细考虑OCP成分,以减轻血栓形成风险.
相关概念视频
Birth Control Methods
2.5K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
2.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
Hormonal Regulation of the Menstrual Cycle
700
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
700
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22


